Results 221 to 230 of about 484,321 (343)

56-71: Long-term Cardiac Resynchronization Therapy Reduces T-wave Alternans in Patients with Cardiomyopathy [PDF]

, 2016
Sachin Nayyar, Adrian Suszko, Rupen Dalvi, Andreu Porta‐Sánchez, Mamta Khurana, Vijay S. Chauhan   +5 more
openalex   +1 more source

Cardiac Hypertrophy in an Infant of a Diabetic Mother: A Case of Reversible Cardiomyopathy

, 2023
Basany Laxman, Naga Priyanka G Gandrakota, Vinay Batthula, Rajesh Babu Gudipati   +3 more
openalex   +1 more source

Idiopathic Cardiomyopathy

Japanese Journal of Medicine, 1977
openaire   +4 more sources

Correction: The rise of rat models for Duchenne muscular dystrophy and therapeutic evaluations. [PDF]

Skelet Muscle
Relaix F, Lafuste P, Taglietti V, Tiret L.   +3 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Stressed out with Sepsis. [PDF]

, 2019
Baram, Michael, Hilton, Robert
core   +1 more source

Takotsubo Cardiomyopathy Following an Emergent Midline Exploratory Laparotomy: A Case Report. [PDF]

Cureus
Abu Ghazal DA, Khalil AA, Abu Ghazal J, Abu Ghazal MA, Alsayed O.   +4 more
europepmc   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Response to Association of Prolonged QTc Interval With Takotsubo Cardiomyopathy: A Neurocardiac Syndrome Inside the Mystery of the Insula of Reil [PDF]

, 2018
Vincenzo Marafioti, Giulia Turri, Salvatore Monaco, Vincenzo Carbone   +3 more
openalex   +1 more source

Study on nutritional status and incidence of sarcopenia in elderly patients with chronic heart failure. [PDF]

Asia Pac J Clin Nutr
Song S, Du H, Lu X, Luo B, Li Z.
europepmc   +1 more source